February 25, 2026

#transplantation — Wednesday, February 25, 2026 (2 items)

hot top new

0		ℹ	An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in Cytomegalovirus-Seropositive Recipients of an Allogeneic Hematopoietic Cell Transplant. (academic.oup.com)	Papanicolaou GA … Badshah C Clinical Infectious Diseases 2026-02-25	#infection #immunity #prophylaxis #transplantation #immunoassay
0		ℹ	Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity for Prediction of Postprophylaxis CMV Disease in a Phase 3 Trial of Letermovir Versus Valganciclovir Prophylaxis in Donor CMV-Seropositive/Recipient CMV-Seronegative Kidney Transplant Recipients. (academic.oup.com)	Limaye AP … Haber B Clinical Infectious Diseases 2026-02-25	#infection #immunity #prophylaxis #transplantation #cmv